American Vein & Lymphatic Society’s Post

Exciting developments in weight loss treatment! 🚀 Dr. Ian Neeland from University Hospitals Harrington Heart & Vascular Institute is leading groundbreaking research on GLP-1 agonists like semaglutide, liraglutide, and tirzepatide. Read how his work aims to deepen our understanding of these meds and shape clinical guidelines for heart and vascular care: https://lnkd.in/eDQt-4Fe

Find out the overexpansion capacity of Angiolite in managing challenging bifurcation lesions. Dr Sabaté demonstrates Angiolite's exceptional performance, perfectly adjusting to varying vessel diameter for optimal outcomes. Curious for more? Dive into the complete clinical case on our website ➡️ https://lnkd.in/dqKuZPkB   #Angiolite #InterventionalCardiology #Overexpansion

Glide to success with CEREGLIDE™ 71 with TruCourse™ Technology– the latest addition to the CERENOVUS Stroke Solutions™! This new catheter is informed by stroke science insights from our Neurothromboembolic Initiative (NTI) that includes robust research and clinical findings to seek and address unmet needs in #stroke: https://bit.ly/3HZmvk7

Find out the overexpansion capacity of Angiolite in managing challenging bifurcation lesions. Dr Manel Sabate demonstrates Angiolite's exceptional performance, perfectly adjusting to varying vessel diameter for optimal outcomes. Curious for more? Dive into the complete clinical case on our website ➡️ https://lnkd.in/dqKuZPkB #Angiolite #InterventionalCardiology #ClinicalCases

Dear Colleagues, A recent publication in the American Journal of Case Reports by authors from the University of Texas at Austin, Austin, TX, USA, highlights the successful extraction of an embolized iliac vein stent from the right heart via a surgical approach. This case report emphasizes the importance of considering alternative methods when percutaneous retrieval fails. With an estimated incidence of 1% to 3%, embolization of peripheral venous stents remains a feared complication. The findings suggest that the surgical approach can be feasible without requiring tricuspid valve repair or replacement. The complete report is now available on the American Journal of Case Reports webpage. | https://lnkd.in/dv6n_2WJ

Case of the Week: This week's case comes from Dr. Thomas Auen (PGY3), Dr. Nila Jones (PGY2), and Dr. Benjamin Swanson (Associate Professor) at University of Nebraska Medical Center. It involves a 71-year-old male with extensive past medical history including severe peripheral vascular disease, alcohol-induced chronic pancreatitis, nicotine dependence, history of deep vein thrombosis, and atrial fibrillation. Medical autopsy revealed the following gross heart findings, with roughened pericardium and adhesions to the surface. Microscopic examination of the anterior and septal region of the left ventricle are shown in subsequent images at 20x and 100x magnification. Which of the following choices best describes the features show in these sections: Let us know what you think: https://lnkd.in/eSXaicdQ

"The Protego™ system reduced operator RE by 99 % compared to Standard Protection. RE was significantly lower at both “Head” level by thyroid median dose 0.0 (0.0, 0,0) vs 5.7 (2.9, 8.2) μSv (p < 0.001), as well as waist dose 0.0 (0.0, 0.0) vs 10.0 (5.0, 16.6) μSv (p < 0.001)." Median HEAD and WAIST levels of 0.0 μSv? The proof is in the research! A new article has just been published on the efficacy our Protego System. HonorHealth Research Institute, Cardiovascular Revascularization Medicine, #CRM, #RadiationProtection #ApronFreeImaging #Cardiovascular Read our full list of scientific studies here➡ https://bit.ly/48XYIfo Follow us ➡ Protego® Radiation Protection System by IDI "Comprehensive radiation shield minimizes operator radiation exposure in coronary and structural heart procedures" by Dr. David Rizik, MD; Kevin P. Gosselin, Robert F. Burke & James A. Goldstein.

Dear Colleagues, We are pleased to share a recent publication from the American Journal of Case Reports by authors from the Beijing University of Chinese Medicine Third Affiliated Hospital, Beijing, China, that sheds light on a rare case of duplicate inferior vena cava (IVC) accompanied by deep venous thrombosis (DVT). The report discusses the optimal treatment plan, determined through thorough imaging examination and venography. It highlights the patient's successful treatment by strategically placing only one filter in the left IVC, resulting in safe thrombolysis and aspiration without the risk of pulmonary embolism. This case report emphasizes the importance of comprehensive consideration for successful endovascular intervention in emergencies. The complete report is now available on the American Journal of Case Reports webpage. | https://lnkd.in/dNbNMHxX

🧠 Stroke Research in Focus: Interview with Michael Knoflach on Radio Tirol This morning, on world stroke day, Michael Knoflach, neurologist and scientist at VASCage GmbH and the Medical University of Innsbruck, shared exciting insights into stroke detection, prevention research, and clinical studies at VASCage! 🎙️🩺 In his Radio Tirol interview (Hallo Tirol, from 8:10 a.m.), Michael covers: 🔹 The latest methods for early stroke detection 🔹 Prevention strategies that reduce risks 🔹 clinical trials on prevention for the general public For those who missed it, you can listen to the interview here: [tirol.orf.at] #clinicaltrial #stroke #WSD2024

Coronary artery anomalies (CAAs) are congenital vascular defects which can remain hidden and asymptomatic. Their incidence varies from 1.3% to 5.64% in coronary #angiography cohorts. What do you see in this image submitted by a team from Portugal and selected for #EuroPCR? Test your knowledge here ➡ https://lnkd.in/dXpEMyqQ #interventionalcardiology #medicalimage #cardioed #cathlab #cathlabteam #interventionalcardiologist